You might be interested in
Long Shortz
Long Shortz with LTR Pharma: Erectile dysfunction help just a spray away
Break It Down
Break it Down: LTR Pharma flexes SPONTAN spray success
Aftermarket
Stockhead TV
Stockhead’s Break it Down brings you today’s leading market news in under 90 seconds.
In this episode, host Sarah Hughan tells all on LTR Pharma (ASX:LTP) prescribing its Spontan formulation to patients for the first time under the Therapeutic Goods Administration’s Special Access Scheme.
Spontan was created to achieve optimal sexual function by assisting erectile dysfunction (ED).
Tune in to get the latest.
While LTR Pharma is a Stockhead advertiser, it did not sponsor this content.